These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31757818)

  • 1. Assessing Deaf patients in the neurology clinic.
    Harris MJ; Atkinson JR; Judd K; Bergson M; Mummery CJ
    Pract Neurol; 2020 Apr; 20(2):132-138. PubMed ID: 31757818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cultural competence in NHS hearing aid clinics: a mixed-methods case study of services for Deaf British sign language users in the UK.
    Hulme C; Young A; Rogers K; Munro KJ
    BMC Health Serv Res; 2023 Dec; 23(1):1440. PubMed ID: 38114981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is speech and language therapy meeting the needs of language minorities? The case of deaf people with neurological impairments.
    Marshall J; Atkinson J; Thacker A; Woll B
    Int J Lang Commun Disord; 2003; 38(1):85-94. PubMed ID: 12569038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferences for communication in clinic from deaf people: a cross-sectional study.
    Middleton A; Turner GH; Bitner-Glindzicz M; Lewis P; Richards M; Clarke A; Stephens D
    J Eval Clin Pract; 2010 Aug; 16(4):811-7. PubMed ID: 20557411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the lived experiences of British Sign Language (BSL) users who access NHS adult hearing aid clinics: an interpretative phenomenological analysis.
    Hulme C; Young A; Munro KJ
    Int J Audiol; 2022 Sep; 61(9):744-751. PubMed ID: 34665678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The theoretical and practical determination of clinical cut-offs for the British Sign Language versions of PHQ-9 and GAD-7.
    Belk RA; Pilling M; Rogers KD; Lovell K; Young A
    BMC Psychiatry; 2016 Nov; 16(1):372. PubMed ID: 27809821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health State Values of Deaf British Sign Language (BSL) Users in the UK: An Application of the BSL Version of the EQ-5D-5L.
    Shields GE; Rogers KD; Young A; Dedotsi S; Davies LM
    Appl Health Econ Health Policy; 2020 Aug; 18(4):547-556. PubMed ID: 31942693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a specialist cognitive clinic for the Deaf community.
    Harris MJ; Au D; Judd K; Atkinson JR; Bergson M; Mummery CJ
    Clin Med (Lond); 2021 Jul; 21(4):e375-e379. PubMed ID: 35192481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deaf signers and hearing aids: motivations, access, competency and service effectiveness.
    Hulme C; Young A; Rogers K; Munro KJ
    Int J Audiol; 2024 Feb; 63(2):136-145. PubMed ID: 36382888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The validation of the Short Warwick-Edinburgh Mental Well-Being Scale (SWEMWBS) with deaf British sign language users in the UK.
    Rogers KD; Dodds C; Campbell M; Young A
    Health Qual Life Outcomes; 2018 Jul; 16(1):145. PubMed ID: 30041627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reliability of British Sign Language and English versions of the Clinical Outcomes in Routine Evaluation--Outcome Measure with d/Deaf populations in the UK: an initial study.
    Rogers K; Evans C; Campbell M; Young A; Lovell K
    Health Soc Care Community; 2014 May; 22(3):278-89. PubMed ID: 24206212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neural systems underlying British Sign Language and audio-visual English processing in native users.
    MacSweeney M; Woll B; Campbell R; McGuire PK; David AS; Williams SC; Suckling J; Calvert GA; Brammer MJ
    Brain; 2002 Jul; 125(Pt 7):1583-93. PubMed ID: 12077007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A qualitative exploration of trial-related terminology in a study involving Deaf British Sign Language users.
    Young A; Oram R; Dodds C; Nassimi-Green C; Belk R; Rogers K; Davies L; Lovell K
    Trials; 2016 Apr; 17(1):219. PubMed ID: 27121282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding dementia: effective information access from the Deaf community's perspective.
    Young A; Ferguson-Coleman E; Keady J
    Health Soc Care Community; 2016 Jan; 24(1):39-47. PubMed ID: 25469427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dementia and the Deaf community: knowledge and service access.
    Ferguson-Coleman E; Keady J; Young A
    Aging Ment Health; 2014; 18(6):674-82. PubMed ID: 24499410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Authentic public and patient involvement with Deaf sign language users: It is not just about language access.
    Young A; Ferguson-Coleman E; Keady J
    Dementia (London); 2018 Nov; 17(8):1001-1010. PubMed ID: 30373465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Translation, validity and reliability of the British Sign Language (BSL) version of the EQ-5D-5L.
    Rogers KD; Pilling M; Davies L; Belk R; Nassimi-Green C; Young A
    Qual Life Res; 2016 Jul; 25(7):1825-34. PubMed ID: 26887955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of early language exposure on the neural system supporting language in deaf and hearing adults.
    Twomey T; Price CJ; Waters D; MacSweeney M
    Neuroimage; 2020 Apr; 209():116411. PubMed ID: 31857205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The knowledge of the Municipal Guard of Curitiba about the Brazilian Sign Language (Libras), deafness and deaf people.
    Pereira AS; Berberian AP; Iachinski LT; Lisboa TR; Tonocchi R; Massi G; Bortolozzi KB; Guarinello AC
    Codas; 2020; 32(4):e20190039. PubMed ID: 32813820
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.